WHAT IS THE REAL IMPACT OF THE HLA-DQA1*05 POLYMORPHISM ON INFLIXIMAB TREATMENT IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE?

Joana Revés  ¹     Ana Catarina Bravo  ¹     Eleonora Davoli  ²     Chiara Tognini  ²     Ana Guedes  ³     Maria Luisa Gloria  ³     Carolina Palmela  ³     Pedro Viana Baptista  ^{2, 2}     Alexandra Fernandes  ^{2, 2}     Joana Torres  ^2    
1 Hospital Beatriz Ângelo, Loures, Portugal
² Faculdade de Ciências e Tecnologia, Universidade NOVA de Lisboa, Caparica, Portugal
³ Glsmed Learning Health Sa, Lisboa, Portugal

Topic
IBD

Session
PP 05 IBD (Posters)

Conference
UEG Week 2023

Citation
United European Gastroenterology Journal 2023; 11 (Supplement 8)